جست‌وجوی استاد و پژوهشگر

Mirela Delibegovicمشاهده پروفایل

استاد

• Diabetes Research
• Cardiovascular Disease
• Metabolic Disorders
• +۳ مورد دیگر

Professor Mirela Delibegovic is a Regius Chair of Physiology at the University of Aberdeen, leading the School of Medicine, Medical Sciences and Nutrition. She holds roles such as Director of the Aberdeen Cardiovascular and Diabetes Centre and Dean for Industrial Engagement in Research. Her expertise spans diabetes physiology, metabolic diseases, and translational research. Delibegovic earned a PhD in Biochemistry from the University of Dundee and a BSc in Pharmacology from the University of Edinburgh. Her research focuses on metabolic and cardiovascular diseases, including diabetes, Alzheimer’s, and atherosclerosis. She has pioneered drug discovery projects and collaborated with industries like EpitogenX and Vertebrate Antibodies Ltd. Key achievements include developing AI-driven diagnostic tools and gene therapies for lipodystrophy. Delibegovic has received awards such as the FRSE (2022), Scottish Knowledge Exchange Awards (2025), and Wellcome Prize (2018). She mentors researchers and serves on grant committees for the British Heart Foundation, Medical Research Council, and others. Her lab has produced notable PhD graduates, including Marina Souza Matos and Sarah Kamli-Salino, and collaborates internationally on projects like AI diagnostics and metabolic therapies. Public engagement is central to her work, including podcasts on insulin discovery and initiatives for gender equality in science. She advocates for knowledge exchange, bridging academia and industry to advance healthcare solutions.

• Obesity Research
• Insulin Resistance
• Cardiometabolic Diseases
• +۶ مورد دیگر

Dr. Nimesh Mody is a Senior Lecturer at the University of Aberdeen, affiliated with the School of Medicine, Medical Sciences and Nutrition and the Aberdeen Cardiovascular & Diabetes Centre. He holds a PhD in Biochemistry from the University of Dundee (2003) and a BSc in Biochemistry from University College London (1998 with First Class Honours). His research focuses on obesity, insulin resistance, and cardiometabolic diseases, particularly exploring retinoid homeostasis and molecular pathways in metabolic disorders. Dr. Mody leads research on how high-fat diets trigger obesity-related comorbidities like diabetes and cardiovascular disease. He investigates Fenretinide’s role in reducing liver steatosis and its dual effects on ceramide-induced atherosclerosis. Collaborations include work with Prof. Mirela Delibegovic on PTP1B signaling and Prof. Bettina Platt on Alzheimer’s disease models. His lab employs mouse models, RNA-seq, lipidomic analysis, and clinical trial approaches. Teaching responsibilities include modules in molecular control of cell function, energy metabolism, and physiology. He coordinates the MSc Cardiovascular Science and Diabetes program. Awards include British Heart Foundation and Wellcome Trust grants, and he guides PhD students like Shehroz Mahmood and Nicola Morrice. Key contributions include identifying Hsd17b13 as a therapeutic target for fatty liver disease and demonstrating Fenretinide’s impact on retinoid pathways. He also evaluates global health issues, such as diabetes prevalence in rural Uganda during the pandemic, and serves on committees like the Athena SWAN Self-Assessment Team.

Karen Altمشاهده پروفایل

مدرس ارشد

• Molecular Imaging
• Antibody Engineering
• Theranostics
• +۳ مورد دیگر

Dr Karen Alt is a Senior Lecturer at the Australian Centre for Blood Diseases, Monash University. She leads the NanoTheranostics Laboratory and specializes in antibody engineering, molecular imaging, and theranostic agent development. Her research focuses on fibrosis detection and imaging techniques for disease progression analysis. Dr Alt has contributed to over 51 publications and holds grants from the Australian Research Council and National Heart Foundation. Education: PhD in Biology (Anti-PSMA Antibody and Fragments for Prostate Cancer Diagnostic and Therapy) from Monash University (2011). Research Interests: Molecular imaging of fibrosis, theranostics, and antibody-based diagnostic tools. Her work integrates bacterial transpeptidase sortase and click chemistry for imaging and drug delivery. Key Projects: Includes the ARC Training Centre for Advanced Radiochemical Technologies (2024–2029) and Translational Kidney Fibrosis Imaging in Diabetes (2024–2025). Awards: ACBD Best Paper Award (2022), MBI Competition 2nd Place (2015), and multiple grant recognitions. Grants/Activities: Collaborates on projects like molecular imaging of cardiac fibrosis and high oxygen water in TBI studies. Active in peer review for NHMRC and journals like PLoS One and Molecular Pharmaceutics. Labs/Teams: Head of NanoTheranostics Lab; collaborates across disciplines in imaging and drug delivery systems.

Sarah Boydمشاهده پروفایل

استاد مدعو

• Systems Biology
• Computational Biology
• Cardiac Research
• +۳ مورد دیگر

Sarah Boyd is an Adjunct Senior Research Fellow at Monash University's Faculty of Medicine with Monash Health. She has maintained an active research career spanning over two decades with significant contributions across multiple domains of biomedical research. Her research interests encompass Systems Biology, Computational Biology, Cardiac Research, Protease Research, and Medical Informatics. Dr. Boyd has developed expertise in computational modeling of biological systems, particularly focusing on cardiac fibroblasts and protease specificity. Her work bridges computational approaches with experimental biology, creating tools and frameworks for understanding complex biological processes. She has made significant contributions to the development of computational tools for protease research and cardiac systems biology, with applications spanning from basic science to clinical applications. Her recent publications demonstrate a strong focus on cardiac biology, with particular emphasis on fibroblast function and identity. She has also maintained research interests in marine biology, specifically coral reef ecosystems and adaptation mechanisms. The trajectory of her work shows increasing integration of computational methods with biological systems across diverse domains. Dr. Boyd has secured research funding from multiple sources including the Australian Research Council (ARC) and personal donations. Her projects include 'Systems modelling of the cardiac fibroblast' (2013-2016), 'Computational techniques for protease research' (2007-2009), and 'Research of protease specificity' (2006). She has also served as Chair of the Communications Committee for the International Society for Systems Biology since 2016. Her research has been widely disseminated through 42 research outputs, including numerous high-impact publications in journals such as eLife, Frontiers in Immunology, Molecular Ecology, and PLoS ONE. Her work has garnered significant attention, with some publications receiving over 80 citations. Her research activities show consistent productivity from 1999 through 2022, demonstrating sustained scholarly engagement throughout her career.

Daniella Brasacchioمشاهده پروفایل

پژوهشگر ارشد

• Blood Cancers
• Cell Biology
• Cancer
• +۳ مورد دیگر

Daniella Brasacchio is a Research Fellow at Monash University's School of Clinical Sciences , working in the Blood Cancer Therapeutics and Blood Cancer Biomarkers laboratories. Her research bridges epigenetics and immunotherapy in hematological cancers while also investigating biomarker discovery in hematopoiesis. Education: PhD in Transcriptional regulation of NFkB in type 1 diabetes mellitus (Monash University, 2007) Bachelor of Science with Honours in Pyridoxamine for diabetes research (Monash University, 2004) Research Focus: Translational epigenetic therapies for blood cancers Molecular biomarker discovery in lymphoma and myeloma Epigenetic mechanisms in diabetes complications Article Trends: 2023: Targeted therapies in MYC-driven lymphoma 2022: Biomarker studies in marginal zone lymphoma 2018-2014: Apoptosis regulation in cancer models 2017-2006: Epigenetic diabetes-vascular interactions Key Collaborations: Australasian Leukaemia and Lymphoma Group (ALLG) Peter MacCallum Cancer Centre Baker Heart and Diabetes Institute Labs: Blood Cancer Therapeutics Laboratory Blood Cancer Biomarkers Laboratory

• Biomedical Imaging
• Neuroimaging
• Neurodegenerative Diseases
• +۳ مورد دیگر

Professor Gary Egan is a leading neuroscientist at Monash University's Monash Biomedical Imaging department. He specializes in neurodegenerative diseases such as Huntington's and Friedreich's ataxia, using advanced imaging techniques like MRI and X-ray synchrotron imaging to map disease progression. His research focuses on early detection of brain changes to enable preventive treatments, leveraging cutting-edge technologies such as deep learning for medical image analysis. Research Interests: Biomedical imaging and neuroimaging techniques Neurodegenerative disease mechanisms Early biomarker identification for neurodegenerative conditions Medical imaging technology development (MRI, PET-MR, synchrotron imaging) Projects: Leading studies on Huntington's disease using MRI to track brain changes Mouse model studies at the Australian Synchrotron to investigate cellular-level disease progression Cross-disciplinary collaborations in AI-driven medical image reconstruction (e.g., CL-MRI, Co-Manifold learning) Grants & Collaborations: Chief investigator on NHMRC-funded projects studying brain structure/function impacts Collaborations in AI-based image analysis frameworks International partnerships in neuroimaging and metabolic connectivity research Labs/Teams: Leads the Monash Biomedical Imaging team, collaborating with institutions like the Victorian Heart Institute (VHI) and Australian Synchrotron. Active in global initiatives like ENIGMA-Ataxia for coordinated neuroimaging research.

• Imaging Biomarkers
• MRI
• PET
• +۶ مورد دیگر

David Wright is an Associate Professor (Research) in the Department of Neuroscience at Monash University, specializing in advanced neuroimaging techniques for neurological diseases. His work focuses on developing MRI-based biomarkers to study traumatic brain injury (TBI), epilepsy, and neurodegenerative disorders. He leads projects such as the NIH-funded Translational platform for epilepsy therapy and biomarker discovery and the Glymphatic System: Novel Biomarker of Disease Severity and Therapeutic Target . Affiliations: Monash Biomedical Imaging (MBI), Central Clinical School. Research Interests: Imaging biomarkers, MRI methodology, TBI pathophysiology, neuroinflammation, and neurodegenerative biomarkers. His research highlights include identifying novel MRI metrics for axonal injury in TBI and demonstrating the role of pre-existing infections (e.g., Toxoplasma gondii) in exacerbating brain damage post-TBI. He collaborates internationally on harmonizing preclinical neuroimaging data to improve translational studies. Key Projects: Translational platform for epilepsy therapy (NIH, 2022–2026) Glymphatic System Biomarkers (2022–2024) His lab, the Wright Group at Monash, focuses on imaging-driven solutions for neurological disorders, with emphasis on clinical translation. Recent work explores CD39-targeted therapies for stroke and glymphatic dysfunction in ALS.

Krystina Lewisمشاهده پروفایل

دانشیار

• Healthcare Service Delivery
• Shared Decision-Making
• Patient and Public Engagement
• +۳ مورد دیگر

Krystina Lewis, Ph.D., is an Associate Professor at the School of Nursing, University of Ottawa, and a Certified Cardiovascular Nurse (CSIC(C)). She leads patient decision aid research at the University of Ottawa Heart Institute and the Ottawa Hospital Research Institute, focusing on shared decision-making frameworks for implantable cardioverter-defibrillators (ICDs) and knowledge translation in cardiovascular care. University of Ottawa (2018) - Ph.D. University of Victoria (2013) - M.Sc. in Nursing Queen's University (2007) - B.Sc. in Nursing Her research prioritizes patient and public engagement in healthcare decisions, particularly cardiovascular device management. She examines value clarification methods, decision aid usability, and implementation science strategies to improve healthcare outcomes through interprofessional collaboration. Key publication trends include systematic reviews on ICD decision-making, mixed-methods studies for patient-centered care, and validation of decision support frameworks. Her work spans clinical trials, meta-analyses, and translational studies in cardiology and nursing practice. Scientific contributions recognized by Governor General's Gold Medal (2019) and multiple best student awards (2011-2015). She contributes to international standards through the International Patient Decision Aid Standards collaborative network.

Stuart Campbellمشاهده پروفایل

استاد

• Cardiac Biomechanics
• Genetic Heart Disease
• Computational Modeling
• +۳ مورد دیگر

Dr. Stuart Campbell is a Professor of Biomedical Engineering at Yale University, leading the Integrative Cardiac Biomechanics Lab. His work bridges computational and experimental approaches to study genetic heart diseases, focusing on multi-scale models integrating genomic, functional, and anatomical data. He develops high-throughput instrumentation to characterize cardiac cells and improve therapeutic strategies. Education: B.S. from Washington State University and Ph.D. from the University of California, San Diego. His research emphasizes understanding mechanisms behind hypertrophic/dilated cardiomyopathy and arrhythmogenic conditions, leveraging tissue engineering and in vitro models. Key interests include cardiac biomechanics, myofilament dynamics, and engineered heart tissues. His lab explores therapies targeting sarcomere dysfunction, with recent work on Tropomyosin mutations and mitochondrial protein regulation. Awards: NSF CAREER Award (2017), Stewart Whitman Award (2011), American Heart Association Fellowships (2008-2012) Grants: Focus on computational modeling, engineered tissues, and genetic heart disease mechanisms. His lab’s work spans from molecular mechanisms to organ-level modeling, with applications in drug development and precision medicine.

• Marine Biology
• Coral Reef Conservation
• Genetics
• +۳ مورد دیگر

Dr. Arne Adam is a Research Officer at the School of the Environment, University of Queensland. He holds a Doctor of Philosophy from Curtin University of Technology. His primary research focuses on marine biology, coral reef conservation, and the application of environmental DNA (eDNA) technologies for ecological monitoring. Key areas include understanding coral genetic connectivity, climate change impacts on marine ecosystems, and developing innovative methods for biodiversity assessment. Adam’s work integrates molecular biology, genetics, and ecological field studies. His recent projects emphasize the use of eDNA metabarcoding to monitor coral diversity and population dynamics in remote regions like northwest Australia and the Kimberley. He also contributes to studies on cardiac development and pancreatic cancer, showcasing interdisciplinary expertise. Publications span coral resilience under climate change, genetic patterns in reef-building corals, and technological advancements in environmental monitoring. His research bridges foundational science with applied conservation strategies, addressing critical challenges in marine and biomedical fields.

Daniel Forgerمشاهده پروفایل

استاد

• Mathematical Biology
• Applied Mathematics
• Dynamical Systems
• +۳ مورد دیگر

Roles & Affiliations: Daniel Forger is the Robert W. and Lynn H. Browne Professor in Science and Director of the Mathematical Center for Applied and Interdisciplinary Mathematics (MCAIM) at the University of Michigan. He holds a joint appointment in the Department of Mathematics, focusing on interdisciplinary research at the intersection of mathematics, biology, and neuroscience. Education: M.S. in Mathematics, Harvard University (1999) Ph.D. in Mathematics, New York University (2003) Research Interests: Forger’s work spans mathematical biology, circadian rhythms, sleep physiology, and dynamical systems. His research develops algorithms and models to analyze real-world data from wearables and sensors, addressing topics like jet lag mitigation, medical intern sleep patterns, and circadian disruption effects. Notably, he created an app to combat sleep issues during social distancing and explored the neuroscience of musical performance through mathematical analysis. Key Contributions: Developed mathematical frameworks for circadian phase estimation using wearable devices Examined the interplay between sleep deprivation and mood in healthcare workers Advanced understanding of circadian rhythms via large-scale biological models Awards & Recognition: Robert W. and Lynn H. Browne Professorship in Science Featured in SIAM News for research on math-music-neuroscience intersections (2018) Recipient of significant research recognition for circadian rhythm studies Labs & Teams: Directs the MCAIM, fostering interdisciplinary collaborations in applied mathematics and computational biology.

Ana Paula Abdala Sheikhمشاهده پروفایل

مدرس ارشد

• Respiratory Physiology
• Cardiovascular Physiology
• Neurodevelopmental Disorders
• +۴ مورد دیگر

Dr. Ana Paula Abdala Sheikh is a Senior Lecturer at the University of Bristol's School of Physiology, Pharmacology & Neuroscience. Her expertise spans respiratory and cardiovascular physiology, with a focus on neurodevelopmental disorders such as Rett syndrome and Pitt-Hopkins syndrome, as well as hypertension and heart failure mechanisms. She holds a BSc, M.Sc., and Ph.D. in relevant fields. Her research integrates experimental models, computational approaches, and translational studies to understand respiratory dysrhythmias, chemoreceptor signaling, and autonomic nervous system dysfunction in disease states. Key projects include investigating therapies targeting the carotid body and purinergic receptors to manage hypertension and exploring electrophysiological mechanisms in Rett syndrome. Her work frequently examines brainstem-respiratory-cardiovascular interactions, with contributions to understanding how genetic mutations and environmental exposures impact these systems. Collaborations within the School include working with Prof. Jules Hancox and Dr. Angus Nightingale on cardiovascular and respiratory neurobiology. Publications highlight advancements in Rett syndrome modeling, drug development for respiratory disorders, and novel hypertension interventions. While no formal student listings are provided, her research likely involves graduate training in physiology and pharmacology.

• Cardiovascular Development
• Genomics
• Developmental Biology
• +۳ مورد دیگر

Dr. Kathryn Hentges is a Reader in the Division of Evolution, Infection and Genomics at the University of Manchester’s Faculty of Biology, Medicine and Health. Her academic journey includes a B.A. from Northwestern University and a Ph.D. from Duke University, followed by postdoctoral research at Baylor College of Medicine. She has held roles as Lecturer (2004-2013), Senior Lecturer (2013-2018), and Reader (2018-present) at the University of Manchester. Her research focuses on cardiovascular development, genomics, and developmental biology. Key interests include coronary vessel formation, left-right axis establishment in embryonic hearts, and the role of essential genes in congenital diseases. She employs mouse models to study genetic factors influencing heart and kidney development, leveraging machine learning for gene prioritization. Teaching responsibilities include courses on genetics and embryology for undergraduate and medical students. She coordinates undergraduate tutorials and is a Senior Fellow of the Higher Education Academy. Current projects involve collaborations on congenital heart defect genetics, supported by grants such as the BHF Centre for Research Excellence (2024-2029). She advises PhD students on topics like cilia function in cardiac development and splicing factor mutations.

Elizabeth Cartwrightمشاهده پروفایل

استاد

• Molecular basis of left ventricular dysfunction
• Heart failure pathophysiology
• Calcium handling in the heart
• +۳ مورد دیگر

Elizabeth Cartwright is a Professor and Head of the Division of Cardiovascular Sciences at the University of Manchester. Her research focuses on molecular mechanisms underlying left ventricular dysfunction and heart failure, with a particular emphasis on the role of plasma membrane calcium pumps (PMCA). She leads the British Heart Foundation 4-year PhD program and the MRes in Cardiovascular Sciences, supervising numerous graduate students. Cartwright holds a PhD from the University of Manchester (1995) and has held academic positions at the University of Leeds and Manchester since 1994. Education: PhD in Cardiovascular Sciences, University of Manchester (1995) Research Fellow, University of Leeds (1994–2002) Lecturer to Professor, University of Manchester (2002–present) Research Interests: Her work investigates novel genes linked to heart failure, PMCA isoforms’ roles in cardiac physiology, and translational approaches to drug development. Key contributions include discoveries about PMCA4’s role in hypertension and PMCA1’s involvement in heart failure with preserved ejection fraction (HFpEF). Teaching & Leadership: Academic Lead for pre-medical/dental programs, PBL tutor for MBChB students, and supervisor for bioscience projects. She directs funded PhD programs and collaborates on projects like the BHF Centre for Research Excellence. Grants & Labs: Principal or co-investigator on grants totaling £multi-million, including projects on Hippo pathway inhibition and miRNA-based therapies. Her lab is part of the Manchester Regenerative Medicine Network and Christabel Pankhurst Institute.

Arthur Arnoldمشاهده پروفایل

استاد پژوهشی

• Sexual Differentiation
• Sex Chromosome Biology
• Epigenetics
• +۳ مورد دیگر

Arthur Arnold is a Distinguished Research Professor in the Department of Integrative Biology and Physiology at the University of California, Los Angeles, and a member of the Brain Research Institute. His research program examines fundamental mechanisms of sexual differentiation, focusing on how sex chromosomes (X/Y) and gonadal hormones contribute to sex differences in physiology, behavior, and disease susceptibility across multiple organ systems. Dr. Arnold's laboratory investigates: Differential expression of X and Y genes in male and female cells Interactions between genetic and hormonal factors in tissue development Evolutionary biology of dosage compensation in avian species Sex-specific mechanisms in cardiovascular, neural, and immune function His work utilizes innovative mouse models including the Four Core Genotypes model to disentangle chromosomal and hormonal effects. Analysis of Dr. Arnold's recent publications (2023-2025) reveals consistent investigation of sex differences in: Cardiovascular and pulmonary pathophysiology Neurodegenerative disease mechanisms Epigenetic regulation of immune function Development of preclinical research frameworks Chromosomal contributions to metabolic disorders This body of work demonstrates his leadership in establishing biological sex as a critical variable in disease research.